BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Hout MC, Hearne E. Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions. Substance Use & Misuse 2016;51:73-84. [DOI: 10.3109/10826084.2015.1082595] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Bates G, Van Hout MC, Teck JTW, McVeigh J. Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduct J 2019;16:75. [PMID: 31888665 DOI: 10.1186/s12954-019-0343-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
2 Germain DJ, Leavey DC, Van Hout PMC, McVeigh PJ. 2,4 dinitrophenol: It's not just for men. Int J Drug Policy 2021;95:102987. [PMID: 33077346 DOI: 10.1016/j.drugpo.2020.102987] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Timms M, Ganio K, Forbes G, Bailey S, Steel R. An immuno polymerase chain reaction screen for the detection of CJC‐1295 and other growth‐hormone‐releasing hormone analogs in equine plasma. Drug Test Anal 2019;11:804-12. [DOI: 10.1002/dta.2554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Henning A, Andreasson J. “Yay, Another Lady Starting a Log!”: Women’s Fitness Doping and the Gendered Space of an Online Doping Forum. Communication & Sport 2021;9:988-1007. [DOI: 10.1177/2167479519896326] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
5 McVeigh J, Hearne E, Boardley I, Bates G, Hope V, Ralphs R, Van Hout MC. Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network. Harm Reduct J 2021;18:107. [PMID: 34657627 DOI: 10.1186/s12954-021-00550-z] [Reference Citation Analysis]
6 Havnes IA, Jørstad ML, Innerdal I, Bjørnebekk A. Anabolic-androgenic steroid use among women - A qualitative study on experiences of masculinizing, gonadal and sexual effects. Int J Drug Policy 2020;:102876. [PMID: 32736958 DOI: 10.1016/j.drugpo.2020.102876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
7 Andreasson J, Johansson T. Negotiating female fitness doping: gender, identity and transgressions. Sport in Society 2021;24:323-39. [DOI: 10.1080/17430437.2019.1672152] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Sverkersson E. ’I’m quite tired of people saying that I don’t do enough or know anything’: male hegemony and resistance in the context of women’s online communication on doping. Sport in Society. [DOI: 10.1080/17430437.2022.2064107] [Reference Citation Analysis]
9 Memdouh S, Gavrilović I, Ng K, Cowan D, Abbate V. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal 2021. [PMID: 34665524 DOI: 10.1002/dta.3183] [Reference Citation Analysis]
10 Sverkersson E, Andreasson J, Johansson T. ‘Sis Science’ and Fitness Doping: Ethnopharmacology, Gender and Risk. Social Sciences 2020;9:55. [DOI: 10.3390/socsci9040055] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Andreasson J, Johansson T. (Un)Becoming a Fitness Doper: Negotiating the Meaning of Illicit Drug Use in a Gym and Fitness Context. Journal of Sport and Social Issues 2020;44:93-109. [DOI: 10.1177/0193723519867589] [Reference Citation Analysis]